| 000 | 01370 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250511213358.0 | ||
| 264 | 0 | _c19911218 | |
| 008 | 199112s 0 0 eng d | ||
| 022 | _a0022-3042 | ||
| 024 | 7 |
_a10.1111/j.1471-4159.1991.tb06407.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTasaki, Y | |
| 245 | 0 | 0 |
_a1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities. _h[electronic resource] |
| 260 |
_bJournal of neurochemistry _cDec 1991 |
||
| 300 |
_a1940-3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_a1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
| 650 | 0 | 4 | _aBrain Chemistry |
| 650 | 0 | 4 |
_aIsoquinolines _xanalysis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aMotor Activity _xdrug effects |
| 650 | 0 | 4 |
_aParkinson Disease _xpsychology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aTetrahydroisoquinolines |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aMakino, Y | |
| 700 | 1 | _aOhta, S | |
| 700 | 1 | _aHirobe, M | |
| 773 | 0 |
_tJournal of neurochemistry _gvol. 57 _gno. 6 _gp. 1940-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1471-4159.1991.tb06407.x _zAvailable from publisher's website |
| 999 |
_c1947108 _d1947108 |
||